Haemophilia care in South Africa: 2004-2007 look back

Haemophilia

Volumn 15, Issue 1, 2009, Pages 135-141

  Mahlangu, Johny N ^a,b  

^a University of the Witwatersrand ^*  (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Care; Data review; Haemophilia; MASAC; South Africa

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

ARTICLE; BLEEDING TENDENCY; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; DRUG USE; FUNDING; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HEMARTHROSIS; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HOME CARE; HUMAN; IMMUNOLOGICAL TOLERANCE; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; RESOURCE ALLOCATION; SOUTH AFRICA; SURGICAL TECHNIQUE; THROMBOCYTOPATHY; TREND STUDY; VACCINATION; VON WILLEBRAND DISEASE;

ADULT; CHILD; DELIVERY OF HEALTH CARE; DRUG UTILIZATION; FACTOR IX; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; SOUTH AFRICA; SURGICAL PROCEDURES, OPERATIVE;

EID: 63049106708     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01807.x     Document Type: Article

References (15)

1. Report to the World Federation of Haemophilia on the activities of the South African Haemophilia Foundation for the year 1971-72. Blut 1972; 25: 203-6.
2. Evatt BL, Black C, Batorova A, Street A, Srivastava A. Comprehensive care for haemophilia around the world. Haemophilia 2004; 10(Suppl. 4): 9-13.
3. Jones JS. Health priorities in SA. S Afr Med J 1999; 89: 1042.
4. Benatar SR, Fleischer TE. Tough priorities. Hastings Cent Rep 2000; 30: 4.
5. Smith PS, Keyes NC, Forman EN. Socioeconomic evaluation of a state-funded comprehensive hemophilia-care program. N Engl J Med 1982; 306: 575-9.
6. Levine PH, Britten AF. Supervised patient-management of hemophilia. A study of 45 patients with hemophilia A and B. Ann Intern Med 1973; 78: 195-201.
7. Soucie JM, Nuss R, Evatt B et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood 2000; 96: 437-42.
8. Evatt BL. The natural evolution of haemophilia care: Developing and sustaining comprehensive care globally. Haemophilia 2006; 12(Suppl. 3): 13-21.
9. Rickard KA. The impact of HIV on health care delivery in haemophilia. Prog Clin Biol Res 1990; 324: 101-11.
10. Berntorp E, Gomperts E, Hoots K, Wong WY. The next generation of hemophilia treatment specialists. Semin Thromb Hemost 2006; 32(Suppl. 2): 39-42.
11. Tezanos Pinto M, Ortiz Z. Haemophilia in the developing world: successes, frustrations and opportunities. Haemophilia 2004; 10(Suppl. 4): 14-9.
12. Isarangkura P. Haemophilia care in the developing world: Benchmarking for excellence. Haemophilia 2002; 8: 205-10.
13. Zweygarth M, Summers RS. A national database for essential drugs in South Africa. Pharm World Sci 2000; 22: 116-7.
14. Darby SC, Kan SW, Spooner RJ et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110: 815-25.
15. Stonebraker JS, Amand RE, Bauman MV et al. Modelling haemophilia epidemiology and treatment modalities to estimate the unconstrained factor VIII demand. Haemophilia 2004; 10: 18-26.